Immune tolerance and transplantation

Seminars in Oncology

Volumn 39, Issue 6, 2012, Pages 629-642

  Alpdogan, Onder ^a   Van Den Brink, Marcel R M ^b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD40 ANTIGEN; CD40 LIGAND; CYCLOPHOSPHAMIDE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; PROGRAMMED DEATH 1 RECEPTOR;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; DRUG EFFECT; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOLOGICAL TOLERANCE; IRRADIATION; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; T CELL DEPLETION; THYMUS; TRANSPLANTATION TOLERANCE;

EID: 84870674685     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2012.10.001     Document Type: Article

References (177)

1. M. Sykes Immune tolerance: mechanisms and application in clinical transplantation JI Intern Med 262 2007 288 310
2. A.D. Griesemer, E.C. Sorenson, M.A. Hardy The role of the thymus in tolerance Transplantation 90 2010 465 474
3. D.L. Mueller Mechanisms maintaining peripheral tolerance Nature Immunol 11 2010 21 27
4. H. Igarashi, S.C. Gregory, T. Yokota, N. Sakaguchi, P.W. Kincade Transcription from the RAG1 locus marks the earliest lymphocyte progenitors in bone marrow Immunity 17 2002 117 130
5. J. Adolfsson, R. Mansson, N. Buza-Vidas Identification of Flt3+ lympho-myeloid stem cells lacking erythro-megakaryocytic potential a revised road map for adult blood lineage commitment Cell 121 2005 295 306
6. M. Kondo, I.L. Weissman, K. Akashi Identification of clonogenic common lymphoid progenitors in mouse bone marrow Cell 91 1997 661 672
7. D. Allman, A. Sambandam, S. Kim Thymopoiesis independent of common lymphoid progenitors Nature Immunol 4 2003 168 174
8. A. Bhandoola, H. von Boehmer, H.T. Petrie, J.C. Zuniga-Pflucker Commitment and developmental potential of extrathymic and intrathymic T cell precursors: plenty to choose from Immunity 26 2007 678 689
9. H.E. Porritt, L.L. Rumfelt, S. Tabrizifard, T.M. Schmitt, J.C. Zuniga-Pflucker, H.T. Petrie Heterogeneity among DN1 prothymocytes reveals multiple progenitors with different capacities to generate T cell and non-T cell lineages Immunity 20 2004 735 745
10. F. Radtke, A. Wilson, G. Stark Deficient T cell fate specification in mice with an induced inactivation of Notch1 Immunity 10 1999 547 558
11. A. Sambandam, I. Maillard, V.P. Zediak Notch signaling controls the generation and differentiation of early T lineage progenitors Nature Immunol 6 2005 663 670
12. J.B. Tan, I. Visan, J.S. Yuan, C.J. Guidos Requirement for Notch1 signals at sequential early stages of intrathymic T cell development Nature Immunol 6 2005 671 679
13. E.Y. Huang, A.M. Gallegos, S.M. Richards, S.M. Lehar, M.J. Bevan Surface expression of Notch1 on thymocytes: correlation with the double-negative to double-positive transition J Immunol 171 2003 2296 2304
14. T.M. Schmitt, M. Ciofani, H.T. Petrie, J.C. Zuniga-Pflucker Maintenance of T cell specification and differentiation requires recurrent notch receptor-ligand interactions J Exp Med 200 2004 469 479
15. M. Ciofani, T.M. Schmitt, A. Ciofani Obligatory role for cooperative signaling by pre-TCR and Notch during thymocyte differentiation J Immunol 172 2004 5230 5239
16. H.T. Petrie, F. Livak, D.G. Schatz, A. Strasser, I.N. Crispe, K. Shortman Multiple rearrangements in T cell receptor alpha chain genes maximize the production of useful thymocytes J Exp Med 178 1993 615 622
17. F. Wang, C.Y. Huang, O. Kanagawa Rapid deletion of rearranged T cell antigen receptor (TCR) Valpha-Jalpha segment by secondary rearrangement in the thymus: role of continuous rearrangement of TCR alpha chain gene and positive selection in the T cell repertoire formation Proc Natl Acad Sci U S A 95 1998 11834 11839
18. C.Y. Huang, B.P. Sleckman, O. Kanagawa Revision of T cell receptor {alpha} chain genes is required for normal T lymphocyte development Proc Natl Acad Sci U S A 102 2005 14356 14361
19. N. Yannoutsos, P. Wilson, W. Yu The role of recombination activating gene (RAG) reinduction in thymocyte development in vivo J Exp Med 194 2001 471 480
20. B. Blom, H. Spits Development of human lymphoid cells Annu Rev Immunol 24 2006 287 320
21. F. Weerkamp, M.R. Baert, M.H. Brugman Human thymus contains multipotent progenitors with T/B lymphoid, myeloid, and erythroid lineage potential Blood 107 2006 3131 3137
22. E.M. Six, D. Bonhomme, M. Monteiro A human postnatal lymphoid progenitor capable of circulating and seeding the thymus J Exp Med 204 2007 3085 3093
23. G.M. Barton, A.Y. Rudensky Requirement for diverse, low-abundance peptides in positive selection of T cells Science 283 1999 67 70
24. T.K. Starr, S.C. Jameson, K.A. Hogquist Positive and negative selection of T cells Annu Rev Immunol 21 2003 139 176
25. C.D. Surh, J. Sprent T-cell apoptosis detected in situ during positive and negative selection in the thymus Nature 372 1994 100 103
26. T. Wekerle, M. Sykes Mixed chimerism as an approach for the induction of transplantation tolerance Transplantation 68 1999 459 467
27. L. Klein, M. Hinterberger, G. Wirnsberger, B. Kyewski Antigen presentation in the thymus for positive selection and central tolerance induction Nature Rev Immunol 9 2009 833 844
28. S.M. Alam, P.J. Travers, J.L. Wung T-cell-receptor affinity and thymocyte positive selection Nature 381 1996 616 620
29. F. Ramsdell, B.J. Fowlkes Clonal deletion versus clonal anergy: the role of the thymus in inducing self tolerance Science 248 1990 1342 1348
30. H. Kishimoto, J. Sprent Negative selection in the thymus includes semimature T cells J Exp Med 185 1997 263 271
31. H. Kishimoto, C.D. Surh, J. Sprent A role for Fas in negative selection of thymocytes in vivo J Exp Med 187 1998 1427 1438
32. H. Kishimoto, J. Sprent Strong TCR ligation without costimulation causes rapid onset of Fas-dependent apoptosis of naive murine CD4+ T cells J Immunol 163 1999 1817 1826
33. J.A. Punt, B.A. Osborne, Y. Takahama, S.O. Sharrow, A. Singer Negative selection of CD4+CD8+ thymocytes by T cell receptor-induced apoptosis requires a costimulatory signal that can be provided by CD28 J Exp Med 179 1994 709 713
34. D.M. Page, L.P. Kane, J.P. Allison, S.M. Hedrick Two signals are required for negative selection of CD4+CD8+ thymocytes J Immunol 151 1993 1868 1880
35. J.E. Buhlmann, S.K. Elkin, A.H. Sharpe A role for the B7-1/B7-2:CD28/CTLA-4 pathway during negative selection J Immunol 170 2003 5421 5428
36. H. Kishimoto, C.D. Surh, J. Sprent A role for Fas in negative selection of thymocytes in vivo J Exp Med 187 1998 1427 1438
37. M.S. Anderson, E.S. Venanzi, L. Klein Projection of an immunological self shadow within the thymus by the aire protein Science 298 2002 1395 1401
38. J.M. Gardner, A.L. Fletcher, M.S. Anderson, S.J. Turley AIRE in the thymus and beyond Curr Opin Immunol 21 2009 582 589
39. I. Ferber, G. Schonrich, J. Schenkel, A.L. Mellor, G.J. Hammerling, B. Arnold Levels of peripheral T cell tolerance induced by different doses of tolerogen Science 263 1994 674 676
40. A.D. Wells, X.C. Li, Y. Li Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance Nat Med 5 1999 1303 1307
41. C. Kurts, M. Cannarile, I. Klebba, T. Brocker Dendritic cells are sufficient to cross-present self-antigens to CD8 T cells in vivo J Immunol 166 2001 1439 1442
42. W.R. Heath, C. Kurts, J.F. Miller, F.R. Carbone Cross-tolerance: a pathway for inducing tolerance to peripheral tissue antigens J Exp Med 187 1998 1549 1553
43. G.M. Davey, C. Kurts, J.F. Miller Peripheral deletion of autoreactive CD8 T cells by cross presentation of self-antigen occurs by a Bcl-2-inhibitable pathway mediated by Bim J Exp Med 196 2002 947 955
44. A.E. Weant, R.D. Michalek, I.U. Khan, B.C. Holbrook, M.C. Willingham, J.M. Grayson Apoptosis regulators Bim and Fas function concurrently to control autoimmunity and CD8+ T cell contraction Immunity 28 2008 218 230
45. J. Hutcheson, J.C. Scatizzi, A.M. Siddiqui Combined deficiency of proapoptotic regulators Bim and Fas results in the early onset of systemic autoimmunity Immunity 28 2008 206 217
46. M.K. Jenkins, P.S. Taylor, S.D. Norton, K.B. Urdahl CD28 delivers a costimulatory signal involved in antigen-specific IL-2 production by human T cells J Immunol 147 1991 2461 2466
47. L.J. Appleman, A. Berezovskaya, I. Grass, V.A. Boussiotis CD28 costimulation mediates T cell expansion via IL-2-independent and IL-2-dependent regulation of cell cycle progression J Immunol 164 2000 144 151
48. G.J. Boonen, A.M. van Dijk, L.F. Verdonck, R.A. van Lier, G. Rijksen, R.H. Medema CD28 induces cell cycle progression by IL-2-independent down-regulation of p27kip1 expression in human peripheral T lymphocytes Eur J Immunol 29 1999 789 798
49. K.A. Frauwirth, J.L. Riley, M.H. Harris The CD28 signaling pathway regulates glucose metabolism Immunity 16 2002 769 777
50. E.A. Rowell, M.C. Walsh, A.D. Wells Opposing roles for the cyclin-dependent kinase inhibitor p27kip1 in the control of CD4+ T cell proliferation and effector function J Immunol 174 2005 3359 3368
51. L.H. Boise, A.J. Minn, P.J. Noel CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL Immunity 3 1995 87 98
52. H. Bour-Jordan, J.H. Esensten, M. Martinez-Llordella, C. Penaranda, M. Stumpf, J.A. Bluestone Intrinsic and extrinsic control of peripheral T-cell tolerance by costimulatory molecules of the CD28/B7 family Immunol Rev 241 2011 180 205
53. A.D. Wells, Q.H. Liu, B. Hondowicz, J. Zhang, L.A. Turka, B.D. Freedman Regulation of T cell activation and tolerance by phospholipase C gamma-1-dependent integrin avidity modulation J Immunol 170 2003 4127 4133
54. E.A. Rowell, L. Wang, W.W. Hancock, A.D. Wells The cyclin-dependent kinase inhibitor p27kip1 is required for transplantation tolerance induced by costimulatory blockade J Immunol 177 2006 5169 5176
55. Y. Li, X.C. Li, X.X. Zheng, A.D. Wells, L.A. Turka, T.B. Strom Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance Nat Med 5 1999 1298 1302
56. P. Waterhouse, J.M. Penninger, E. Timms Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4 Science 270 1995 985 988
57. T.L. Walunas, D.J. Lenschow, C.Y. Bakker CTLA-4 can function as a negative regulator of T cell activation Immunity 1 1994 405 413
58. T.L. Walunas, C.Y. Bakker, J.A. Bluestone CTLA-4 ligation blocks CD28-dependent T cell activation J Exp Med 183 1996 2541 2550
59. H. Lin, J.C. Rathmell, G.S. Gray, C.B. Thompson, J.M. Leiden, M.L. Alegre Cytotoxic T lymphocyte antigen 4 (CTLA4) blockade accelerates the acute rejection of cardiac allografts in CD28-deficient mice: CTLA4 can function independently of CD28 J Exp Med 188 1998 199 204
60. P.S. Linsley, P.M. Wallace, J. Johnson Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule Science 257 1992 792 795
61. T.C. Pearson, D.Z. Alexander, R. Hendrix CTLA4-Ig plus bone marrow induces long-term allograft survival and donor specific unresponsiveness in the murine model Evidence for hematopoietic chimerism Transplantation 61 1996 997 1004
62. J.N. Blattman, P.D. Greenberg PD-1 blockade: rescue from a near-death experience Nature Immunol 7 2006 227 228
63. M.E. Keir, G.J. Freeman, A.H. Sharpe PD-1 regulates self-reactive CD8+ T cell responses to antigen in lymph nodes and tissues J Immunol 179 2007 5064 5070
64. T. Okazaki, T. Honjo The PD-1-PD-L pathway in immunological tolerance Trends Immunol 27 2006 195 201
65. H. Nishimura, T. Okazaki, Y. Tanaka Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice Science 291 2001 319 322
66. H. Nishimura, M. Nose, H. Hiai, N. Minato, T. Honjo Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor Immunity 11 1999 141 151
67. L. Chen Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity Nature Rev Immunol 4 2004 336 347
68. J.M. Chemnitz, R.V. Parry, K.E. Nichols, C.H. June, J.L. Riley SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activation J Immunol 173 2004 945 954
69. R.V. Parry, J.M. Chemnitz, K.A. Frauwirth CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms Mol Cell Biol 25 2005 9543 9553
70. S.J. Lin, C.D. Peacock, K. Bahl, R.M. Welsh Programmed death-1 (PD-1) defines a transient and dysfunctional oligoclonal T cell population in acute homeostatic proliferation J Exp Med 204 2007 2321 2333
71. F. Haspot, T. Fehr, C. Gibbons Peripheral deletional tolerance of alloreactive CD8 but not CD4 T cells is dependent on the PD-1/PD-L1 pathway Blood 112 2008 2149 2155
72. M.J. Butte, M.E. Keir, T.B. Phamduy, A.H. Sharpe, G.J. Freeman Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses Immunity 27 2007 111 122
73. J.J. Park, R. Omiya, Y. Matsumura B7-H1/CD80 interaction is required for the induction and maintenance of peripheral T-cell tolerance Blood 116 2010 1291 1298
74. E.D. Reynoso, K.G. Elpek, L. Francisco Intestinal tolerance is converted to autoimmune enteritis upon PD-1 ligand blockade J Immunol 182 2009 2102 2112
75. H. Dong, G. Zhu, K. Tamada, D.B. Flies, J.M. van Deursen, L. Chen B7-H1 determines accumulation and deletion of intrahepatic CD8(+) T lymphocytes Immunity 20 2004 327 336
76. Y. Latchman, C.R. Wood, T. Chernova PD-L2 is a second ligand for PD-1 and inhibits T cell activation Nat Immunol 2 2001 261 268
77. A. Habicht, R. Kewalaramani, M.D. Vu Striking dichotomy of PD-L1 and PD-L2 pathways in regulating alloreactive CD4(+) and CD8(+) T cells in vivo Am J Transplant 7 2007 2683 2692
78. S. Lederman, M.J. Yellin, A. Krichevsky, J. Belko, J.J. Lee, L. Chess Identification of a novel surface protein on activated CD4+ T cells that induces contact-dependent B cell differentiation (help) J Exp Med 175 1992 1091 1101
79. J.D. Laman, E. Claassen, R.J. Noelle Functions of CD40 and its ligand, gp39 (CD40L) Crit Rev Immunol 16 1996 59 108
80. C. Caux, C. Massacrier, B. Vanbervliet Activation of human dendritic cells through CD40 cross-linking J Exp Med 180 1994 1263 1272
81. K. Karmann, C.C. Hughes, J. Schechner, W.C. Fanslow, J.S. Pober CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression Proc Natl Acad Sci U S A 92 1995 4342 4346
82. R.C. Rickert, J. Jellusova, A.V. Miletic Signaling by the tumor necrosis factor receptor superfamily in B-cell biology and disease Immunol Rev 244 2011 115 133
83. M.R. Clarkson, M.H. Sayegh T-cell costimulatory pathways in allograft rejection and tolerance Transplantation 80 2005 555 563
84. C.P. Larsen, E.T. Elwood, D.Z. Alexander Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways Nature 381 1996 434 438
85. C.P. Larsen, D.Z. Alexander, D. Hollenbaugh CD40-gp39 interactions play a critical role during allograft rejection Suppression of allograft rejection by blockade of the CD40-gp39 pathway Transplantation 61 1996 4 9
86. A.D. Kirk, D.M. Harlan, N.N. Armstrong CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates Proc Natl Acad Sci U S A 94 1997 8789 8794
87. A.D. Kirk, L.C. Burkly, D.S. Batty Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates Nat Med 5 1999 686 693
88. R.K. Gershon, K. Kondo Cell interactions in the induction of tolerance: the role of thymic lymphocytes Immunology 18 1970 723 737
89. K. Wing, S. Sakaguchi Regulatory T cells exert checks and balances on self tolerance and autoimmunity Nature Immunol 11 2010 7 13
90. S. Sakaguchi, N. Sakaguchi, M. Asano, M. Itoh, M. Toda Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25) Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases J Immunol 155 1995 1151 1164
91. B. Singh, S. Read, C. Asseman Control of intestinal inflammation by regulatory T cells Immunol Rev 182 2001 190 200
92. M. Asano, M. Toda, N. Sakaguchi, S. Sakaguchi Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation J Exp Med 184 1996 387 396
93. M. Itoh, T. Takahashi, N. Sakaguchi Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance J Immunol 162 1999 5317 5326
94. A. O'Garra, P. Vieira Regulatory T cells and mechanisms of immune system control Nat Med 10 2004 801 805
95. S. Hori, T. Nomura, S. Sakaguchi Control of regulatory T cell development by the transcription factor Foxp3 Science 299 2003 1057 1061
96. J.D. Fontenot, M.A. Gavin, A.Y. Rudensky Foxp3 programs the development and function of CD4+CD25+ regulatory T cells Nature Immunol 4 2003 330 336
97. R. Khattri, T. Cox, S.A. Yasayko, F. Ramsdell An essential role for Scurfin in CD4+CD25+ T regulatory cells Nature Immunol 4 2003 337 342
98. W. Chen, W. Jin, N. Hardegen Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3 J Exp Med 198 2003 1875 1886
99. I. Apostolou, H. von Boehmer In vivo instruction of suppressor commitment in naive T cells J Exp Med 199 2004 1401 1408
100. K. Kretschmer, I. Apostolou, D. Hawiger, K. Khazaie, M.C. Nussenzweig, H. von Boehmer Inducing and expanding regulatory T cell populations by foreign antigen Nature Immunol 6 2005 1219 1227
101. S. Huber, C. Schramm, H.A. Lehr Cutting edge: TGF-beta signaling is required for the in vivo expansion and immunosuppressive capacity of regulatory CD4+CD25+ T cells J Immunol 173 2004 6526 6531
102. J.C. Marie, J.J. Letterio, M. Gavin, A.Y. Rudensky TGF-beta1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells J Exp Med 201 2005 1061 1067
103. Y. Chen, V.K. Kuchroo, J. Inobe, D.A. Hafler, H.L. Weiner Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis Science 265 1994 1237 1240
104. S. Sakaguchi, T. Yamaguchi, T. Nomura, M. Ono Regulatory T cells and immune tolerance Cell 133 2008 775 787
105. B.H. Hahn, R.P. Singh, A. La Cava, F.M. Ebling Tolerogenic treatment of lupus mice with consensus peptide induces Foxp3-expressing, apoptosis-resistant, TGFbeta-secreting CD8+ T cell suppressors J Immunol 175 2005 7728 7737
106. Y.G. Tsai, K.D. Yang, D.M. Niu, J.W. Chien, C.Y. Lin TLR2 agonists enhance CD8+Foxp3+ regulatory T cells and suppress Th2 immune responses during allergen immunotherapy J Immunol 184 2010 7229 7237
107. R.J. Robb, K.E. Lineburg, R.D. Kuns Identification and expansion of highly suppressive CD8+FoxP3+ regulatory T cells after experimental allogeneic bone marrow transplantation Blood 119 2012 5898 5908
108. E.M. Shevach CD4+ CD25+ suppressor T cells: more questions than answers Nature Rev Immunol 2 2002 389 400
109. B. Sadlack, H. Merz, H. Schorle, A. Schimpl, A.C. Feller, I. Horak Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene Cell 75 1993 253 261
110. B. Sadlack, J. Lohler, H. Schorle Generalized autoimmune disease in interleukin-2-deficient mice is triggered by an uncontrolled activation and proliferation of CD4+ T cells Eur J Immunol 25 1995 3053 3059
111. G.C. Furtado, M.A. Curotto de Lafaille, N. Kutchukhidze, J.J. Lafaille Interleukin 2 signaling is required for CD4(+) regulatory T cell function J Exp Med 196 2002 851 857
112. A.M. Thornton, E.E. Donovan, C.A. Piccirillo, E.M. Shevach Cutting edge: IL-2 is critically required for the in vitro activation of CD4+CD25+ T cell suppressor function J Immunol 172 2004 6519 6523
113. T.R. Malek, A.L. Bayer Tolerance, not immunity, crucially depends on IL-2 Nature Rev Immunol 4 2004 665 674
114. H. von Boehmer Mechanisms of suppression by suppressor T cells Nature Immunol 6 2005 338 344
115. C.A. Piccirillo, J.J. Letterio, A.M. Thornton CD4(+)CD25(+) regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta1 production and responsiveness J Exp Med 196 2002 237 246
116. C. Asseman, S. Mauze, M.W. Leach, R.L. Coffman, F. Powrie An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation J Exp Med 190 1999 995 1004
117. S. Paust, L. Lu, N. McCarty, H. Cantor Engagement of B7 on effector T cells by regulatory T cells prevents autoimmune disease Proc Natl Acad Sci U S A 101 2004 10398 10403
118. U. Grohmann, C. Orabona, F. Fallarino CTLA-4-Ig regulates tryptophan catabolism in vivo Nat Immunol 3 2002 1097 1101
119. F. Fallarino, U. Grohmann, K.W. Hwang Modulation of tryptophan catabolism by regulatory T cells Nat Immunol 4 2003 1206 1212
120. B. Birebent, R. Lorho, H. Lechartier Suppressive properties of human CD4+CD25+ regulatory T cells are dependent on CTLA-4 expression Eur J Immunol 34 2004 3485 3496
121. T. Takahashi, T. Tagami, S. Yamazaki Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4 J Exp Med 192 2000 303 310
122. W.J. Grossman, J.W. Verbsky, W. Barchet, M. Colonna, J.P. Atkinson, T.J. Ley Human T regulatory cells can use the perforin pathway to cause autologous target cell death Immunity 21 2004 589 601
123. P.A. Taylor, C.J. Lees, B.R. Blazar The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality Blood 99 2002 3493 3499
124. P.A. Taylor, R.J. Noelle, B.R. Blazar CD4(+)CD25(+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade J Exp Med 193 2001 1311 1318
125. P. Hoffmann, J. Ermann, M. Edinger, C.G. Fathman, S. Strober Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation J Exp Med 196 2002 389 399
126. L. Graca, S. Thompson, C.Y. Lin, E. Adams, S.P. Cobbold, H. Waldmann Both CD4(+)CD25(+) and CD4(+)CD25(-) regulatory cells mediate dominant transplantation tolerance J Immunol 168 2002 5558 5565
127. S.P. Cobbold, R. Castejon, E. Adams Induction of foxP3+ regulatory T cells in the periphery of T cell receptor transgenic mice tolerized to transplants J Immunol 172 2004 6003 6010
128. G. Feng, K.J. Wood, A. Bushell Interferon-gamma conditioning ex vivo generates CD25+CD62L+Foxp3+ regulatory T cells that prevent allograft rejection: potential avenues for cellular therapy Transplantation 86 2008 578 589
129. C.I. Kingsley, M. Karim, A.R. Bushell, K.J. Wood CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses J Immunol 168 2002 1080 1086
130. H. Waldmann, L. Graca, S. Cobbold, E. Adams, M. Tone, Y. Tone Regulatory T cells and organ transplantation SeminI Immunol 16 2004 119 126
131. K.L. Hippen, J.L. Riley, C.H. June, B.R. Blazar Clinical perspectives for regulatory T cells in transplantation tolerance Semin Immunol 23 2011 462 468
132. K.L. Hippen, S.C. Merkel, D.K. Schirm Massive ex vivo expansion of human natural regulatory T cells (T(regs)) with minimal loss of in vivo functional activity Sci Translation Med 3 2011 83ra41
133. C.G. Brunstein, J.S. Miller, Q. Cao Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics Blood 117 2011 1061 1070
134. reg s prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation Blood 117 2011 3921 3928
135. A. Bendelac, M.N. Rivera, S.H. Park, J.H. Roark Mouse CD1-specific NK1 T cells: development, specificity, and function Ann Rev Immunol 15 1997 535 562
136. D. Zeng, D. Lewis, S. Dejbakhsh-Jones Bone marrow NK1.1(-) and NK1.1(+) T cells reciprocally regulate acute graft versus host disease J Exp Med 189 1999 1073 1081
137. M. Higuchi, D. Zeng, J. Shizuru Immune tolerance to combined organ and bone marrow transplants after fractionated lymphoid irradiation involves regulatory NK T cells and clonal deletion J Immunol 169 2002 5564 5570
138. F. Lan, D. Zeng, M. Higuchi, J.P. Higgins, S. Strober Host conditioning with total lymphoid irradiation and antithymocyte globulin prevents graft-versus-host disease: the role of CD1-reactive natural killer T cells Biol Blood Marrow Transplant 9 2003 355 363
139. reg s are required for tolerance to combined bone marrow and organ transplants Blood 119 2012 1581 1589
140. T. Leemhuis, S. Wells, C. Scheffold, M. Edinger, R.S. Negrin A phase I trial of autologous cytokine-induced killer cells for the treatment of relapsed Hodgkin disease and non-Hodgkin lymphoma Biol Blood Marrow Transplant 11 2005 181 187
141. G.G. Laport, K. Sheehan, J. Baker Adoptive immunotherapy with cytokine-induced killer cells for patients with relapsed hematologic malignancies after allogeneic hematopoietic cell transplantation Biol Blood Marrow Transplant 17 2011 1679 1687
142. R.G. Miller An immunological suppressor cell inactivating cytotoxic T-lymphocyte precursor cells recognizing it Nature 287 1980 544 546
143. P.J. Fink, H.G. Rammensee, M.J. Bevan Cloned cytolytic T cells can suppress primary cytotoxic responses directed against them J Immunol 133 1984 1775 1781
144. L. Zhang, J. Shannon, J. Sheldon, H.S. Teh, T.W. Mak, R.G. Miller Role of infused CD8+ cells in the induction of peripheral tolerance J Immunol 152 1994 2222 2228
145. S. Reich-Zeliger, Y. Zhao, R. Krauthgamer, E. Bachar-Lustig, Y. Reisner Anti-third party CD8+ CTLs as potent veto cells: coexpression of CD8 and FasL is a prerequisite Immunity 13 2000 507 515
146. S.R. Sambhara, R.G. Miller Programmed cell death of T cells signaled by the T cell receptor and the alpha 3 domain of class I MHC Science 252 1991 1424 1427
147. K. Sugiura, M. Inaba, H. Ogata Wheat germ agglutinin-positive cells in a stem cell-enriched fraction of mouse bone marrow have potent natural suppressor activity Proc Natl Acad Sci U S A 85 1988 4824 4826
148. C.L. Kaufman, Y.L. Colson, S.M. Wren, S. Watkins, R.L. Simmons, S.T. Ildstad Phenotypic characterization of a novel bone marrow-derived cell that facilitates engraftment of allogeneic bone marrow stem cells Blood 84 1994 2436 2446
149. K. Hiruma, H. Nakamura, P.A. Henkart, R.E. Gress Clonal deletion of postthymic T cells: veto cells kill precursor cytotoxic T lymphocytes J Exp Med 175 1992 863 868
150. E. Bachar-Lustig, H.W. Li, H. Marcus, Y. Reisner Tolerance induction by megadose stem cell transplants: synergism between SCA-1+ Lin- cells and nonalloreactive T cells Transplant Proc 30 1998 4007 4008
151. H. Gur, R. Krauthgamer, A. Berrebi Tolerance induction by megadose hematopoietic progenitor cells: expansion of veto cells by short-term culture of purified human CD34(+) cells Blood 99 2002 4174 4181
152. Y. Reisner, H. Gur, S. Reich-Zeliger, M.F. Martelli, E. Bachar-Lustig Hematopoietic stem cell transplantation across major genetic barriers: tolerance induction by megadose CD34 cells and other veto cells Ann NY Acad Sci 1044 2005 70 83
153. Y. Reisner, M.F. Martelli From 'megadose' haploidentical hematopoietic stem cell transplants in acute leukemia to tolerance induction in organ transplantation Blood Cells Mol Dis 40 2008 1 7
154. L. Luznik, L.W. Engstrom, R. Iannone, E.J. Fuchs Posttransplantation cyclophosphamide facilitates engraftment of major histocompatibility complex-identical allogeneic marrow in mice conditioned with low-dose total body irradiation Biol Blood Marrow Transplant 8 2002 131 138
155. P.V. O'Donnell, L. Luznik, R.J. Jones Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using posttransplantation cyclophosphamide Biol Blood Marrow Transplant 8 2002 377 386
156. D. Grosso, M. Carabasi, J. Filicko-O'Hara A 2-step approach to myeloablative haploidentical stem cell transplantation: a phase 1/2 trial performed with optimized T-cell dosing Blood 118 2011 4732 4739
157. Y.L. Kasamon, L. Luznik, M.S. Leffell Nonmyeloablative HLA-haploidentical bone marrow transplantation with high-dose posttransplantation cyclophosphamide: effect of HLA disparity on outcome Biol Blood Marrow Transplant 16 2010 482 489
158. M. Sykes, G.L. Szot, K.A. Swenson, D.A. Pearson Induction of high levels of allogeneic hematopoietic reconstitution and donor-specific tolerance without myelosuppressive conditioning Nat Med 3 1997 783 787
159. Y. Tomita, A. Khan, M. Sykes Role of intrathymic clonal deletion and peripheral anergy in transplantation tolerance induced by bone marrow transplantation in mice conditioned with a nonmyeloablative regimen J Immunol 153 1994 1087 1098
160. C.A. Huang, Y. Fuchimoto, R. Scheier-Dolberg, M.C. Murphy, D.M. Neville Jr, D.H. Sachs Stable mixed chimerism and tolerance using a nonmyeloablative preparative regimen in a large-animal model J Clin Invest 105 2000 173 181
161. L.H. Buhler, T.R. Spitzer, M. Sykes Induction of kidney allograft tolerance after transient lymphohematopoietic chimerism in patients with multiple myeloma and end-stage renal disease Transplantation 74 2002 1405 1409
162. J.D. Scandling, S. Busque, S. Dejbakhsh-Jones Tolerance and chimerism after renal and hematopoietic-cell transplantation N Engl J Med 358 2008 362 368
163. T. Kawai, A.B. Cosimi, T.R. Spitzer HLA-mismatched renal transplantation without maintenance immunosuppression N Engl J Med 358 2008 353 361
164. J. Leventhal, M. Abecassis, J. Miller Chimerism and tolerance without GVHD or engraftment syndrome in HLA-mismatched combined kidney and hematopoietic stem cell transplantation Sci Translation Med 4 2012 124ra28
165. I.J. Fugier-Vivier, F. Rezzoug, Y. Huang Plasmacytoid precursor dendritic cells facilitate allogeneic hematopoietic stem cell engraftment J Exp Med 201 2005 373 383
166. D.A. Mavroudis, Y.Z. Jiang, N. Hensel Specific depletion of alloreactivity against haplotype mismatched related individuals by a recombinant immunotoxin: a new approach to graft-versus-host disease prophylaxis in haploidentical bone marrow transplantation Bone Marrow Transplant 17 1996 793 799
167. S.R. Solomon, S. Mielke, B.N. Savani Selective depletion of alloreactive donor lymphocytes: a novel method to reduce the severity of graft-versus-host disease in older patients undergoing matched sibling donor stem cell transplantation Blood 106 2005 1123 1129
168. X.Z. Yu, S.J. Bidwell, P.J. Martin, C. Anasetti Anti-CD3 epsilon F(ab')2 prevents graft-versus-host disease by selectively depleting donor T cells activated by recipient alloantigens J Immunol 166 2001 5835 5839
169. P.A. Carpenter, J. Lowder, L. Johnston A phase II multicenter study of visilizumab, humanized anti-CD3 antibody, to treat steroid-refractory acute graft-versus-host disease Biol Blood Marrow Transplant 11 2005 465 471
170. P.A. Carpenter, F.R. Appelbaum, L. Corey A humanized non-FcR-binding anti-CD3 antibody, visilizumab, for treatment of steroid-refractory acute graft-versus-host disease Blood 99 2002 2712 2719
171. A.D. Kirk, D.A. Hale, R.B. Mannon Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (CAMPATH-1H) Transplantation 76 2003 120 129
172. A.D. Kirk, R.B. Mannon, D.E. Kleiner Results from a human renal allograft tolerance trial evaluating T-cell depletion with alemtuzumab combined with deoxyspergualin Transplantation 80 2005 1051 1059
173. A.D. Salama, K.L. Womer, M.H. Sayegh Clinical transplantation tolerance: many rivers to cross J Immunol 178 2007 5419 5423
174. J. Mestas, C.C. Hughes Of mice and not men: differences between mouse and human immunology J Immunol 172 2004 2731 2738
175. G. Suntharalingam, M.R. Perry, S. Ward Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412 N Engl J Med 355 2006 1018 1028
176. T. Kawai, D. Andrews, R.B. Colvin, D.H. Sachs, A.B. Cosimi Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand Nat Med 6 2000 114
177. I. Koyama, T. Kawai, D. Andrews Thrombophilia associated with anti-CD154 monoclonal antibody treatment and its prophylaxis in nonhuman primates Transplantation 77 2004 460 462